Role of Exogenous Corticotropin-releasing Hormone in Cerebral Infarction-related Gastrointestinal Barrier Dysfunction
-
摘要:
目的 探讨外源性促肾上腺皮质激素释放激素(corticotropin-releasing hormone, CRH)在脑梗死胃肠屏障破坏中的作用。 方法 雄性Wistar大鼠40只, 随机分为伪手术组(C组)、脑梗死组(I组)、脑梗死+脑室CRH拮抗剂组(A组)、脑梗死+腹腔CRH组(H组), 每组10只。留尿检测24 h尿肾上腺素、去甲肾上腺素、皮质醇含量及蔗糖排出率, 造模后24 h行血浆二胺氧化酶活性、D-乳酸浓度检测; 行胃大体Guth评分, Western blot法检测下丘脑、胃、空肠、结肠CRH蛋白的表达。 结果 各组应激强度指标24 h尿肾上腺素、去甲肾上腺素、皮质醇含量变化趋势一致:与C组比较, I组、H组上述指标均显著升高(P均 < 0.05);与I组比较, A组上述指标均显著下降(P均 < 0.05), H组有轻度升高趋势, 但差异无统计学意义; 与A组比较, H组上述指标均显著升高(P均 < 0.05)。各组尿蔗糖排出率、胃Guth评分、血浆二胺氧化酶活性、血浆D-乳酸及下丘脑、胃、空肠、结肠CRH含量变化趋势一致:与C组比较, I组上述指标均显著升高(P均 < 0.05);与I组比较, A组上述指标均显著下降(P均 < 0.05), H组上述指标亦显著下降(P均 < 0.05);A组和H组间上述指标差异无统计学意义。 结论 脑梗死时胃肠道通透性增加, 黏膜屏障破坏; 中枢使用CRH受体拮抗剂能缓解脑梗死相关的胃肠屏障破坏; 外周给予CRH会抑制脑内和胃肠道局部CRH蛋白的表达, 同样能缓解脑梗死相关的胃肠屏障破坏。 -
关键词:
- 促肾上腺皮质激素释放激素 /
- 脑梗死 /
- 胃肠黏膜屏障 /
- 应激
Abstract:Objective To explore the role of exogenous corticotropin-releasing hormone (CRH) in cerebral infarction-related gastrointestinal barrier dysfunction. Methods Forty male Wistar rats were randomly divided into pseudo-operation group (group C), cerebral infarction group (group Ⅰ), cerebral infarction + intracerebroventricular CRH antagonist group (group A), and cerebral infarction + intraperitoneal CRH group (group H), 10 rats for each group. Urine samples were collected to determine the levels of 24-hour urine epinephrine, norepinephrine, cortisol, and sucrose. Blood samples were taken 24 hours after establishment of the models to determine the activity of diamine oxidase (DAO) and the concentration of D-lactic acid (D-lac). The stomach was taken to determine gastric Guth score, and the tissues of hypothalamus, stomach, jejunum and colon were all taken to determine tissue CRH protein expression using Western blot. Results The changes of urinary cortisol and catecholamine were nearly the same:these indicators in group Ⅰ and group H were significantly higher than those in group C (P < 0.05);in group A were significantly lower than those in group Ⅰ (P < 0.05), in group H were slightly higher than those in group Ⅰ, but with no significant difference; in group H were significantly higher than those in group A (P < 0.05). The changes of urine sucrose exertion, gastric Guth score, plasma DAO activity, plasma D-lac, as well as hypothalamus and gastrointestinal CRH protein content were nearly the same:these indicators in group Ⅰ were significantly higher than those in group C (P < 0.05);in group A were significantly lower than those in group Ⅰ (P < 0.05), in group H were also significantly lower than in group Ⅰ (P < 0.05);however, there was no significant difference between group A and group H. Conclusions After cerebral infarction, gastrointestinal barrier function is damaged. Central use of CRH blocker can decrease cerebral infarction-related gastrointestinal barrier dysfunction. Peripheral use of exogenous CRH can decrease the expression of CRH protein in the brain and the gastrointestinal tract, and also can decrease cerebral infarction-related gastrointestinal barrier dysfunction. -
图 2 各组实验大鼠胃组织中CRH蛋白相对含量比较
CRH:同图 1;与C组比较,* *P<0.01;与I组比较,††P<0.01;与A组比较,‡‡P<0.01
图 3 各组实验大鼠空肠组织中CRH蛋白相对含量比较
CRH:同图 1;与C组比较,* *P<0.01;与I组比较,††P<0.01;与A组比较,‡‡P<0.01
图 4 各组实验大鼠结肠组织中CRH蛋白相对含量比较
CRH:同图 1;与C组比较,*P<0.05,* *P<0.01;与I组比较,††P<0.01;与A组比较,‡P<0.05,‡‡P<0.01
表 1 各组大鼠实验室指标及胃大体评分结果(x ±s, n=10)
组别 24 h尿肾上腺素
(ng)24 h尿去甲肾上腺素
(ng)24 h尿皮质醇
(ng)尿蔗糖排出率
(%)胃Guth评分 血浆DAO活性
(U/L)血浆D-乳酸
(mg/L)C组 13.11±7.56† 156.65±60.28† 106.13±47.47†† 0.54±0.29†† 1.5±1.4††‡‡ 16.33±5.41†† 7.35±1.24† I组 42.28±19.86*‡ 265.96±82.09*‡ 239.85±73.85**‡‡ 2.19±0.88**‡‡ 13.9±5.3**‡‡ 26.37±8.09**‡ 14.37±3.70*‡ A组 17.93±6.25† 160.50±34.88† 127.90±47.17† 0.82±0.36†† 4.7±2.8**†† 19.47±5.89† 7.51±1.22† H组 70.96±27.07**‡‡ 339.25±109.24*‡ 248.87±93.38**‡‡ 0.96±0.42†† 7.1±4.5**† 19.68±4.35† 9.22±1.95† DAO:二胺氧化酶;与C组比较,* P<0.05, * * P<0.01;与I组比较,†P<0.05, ††P<0.01;与A组比较,‡P<0.05, ‡‡P<0.01 -
[1] Wolfram M, Bellingrath S, Feuerhahn N, et al. Emotional exhaustion and overcommitment to work are differentially associated with hypothalamus-pituitary-adrenal (HPA) axis responses to a low-dose ACTH1-24(Synacthen) and dexamethasone-CRH test in healthy school teachers[J]. Stress, 2013, 16:54-64. doi: 10.3109/10253890.2012.683465 [2] Maras PM, Baram TZ. Sculpting the hippocampus from within:stress, spines, and CRH[J].Trends Neurosci, 2012, 35:315-324. doi: 10.1016/j.tins.2012.01.005 [3] Takadanohara H, Catanzaro R, Chui de H, et al. Beneficial effect of a symbiotic preparation with S. boulardii lysate in mild stress-induced gut hyper-permeability[J].Acta Biomed, 2012, 83:208-216. https://www.ncbi.nlm.nih.gov/pubmed/23762997 [4] Morimoto A, Nakamori T, Morimoto K, et al. The central role of corticotrophin-releasing factor (CRF-41) in psychological stress in rats[J]. J Physiol, 1993, 460:221-229. doi: 10.1113/jphysiol.1993.sp019468 [5] Mahmood T, Yang PC.Western blot:technique, theory, and trouble shooting[J].N Am J Med Sci, 2012, 4:429-434. doi: 10.4103/1947-2714.100998 [6] 刘业成, 齐志伟, 崔晓雨, 等.急性缺血性脑卒中对犬胃屏障功能的影响[J].中国临床营养杂志, 2008, 16:36-40. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zglcyyzz200801009 [7] 刘业成, 齐志伟, 马遂, 等.急性缺血性脑卒中时胃黏膜细胞凋亡和胃屏障损伤的关系[J].中国医学科学院学报, 2008, 30:149-152. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyxkxyxb200802007 [8] Cakmaz R, Buyukasik O, Kahramansoy N, et al. A combination of plasma DAO and citrulline levels as a potential marker for acute mesenteric ischemia[J].Libyan J Med, 2013, 8:1-6. http://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=88858342&site=ehost-live [9] 刘业成, 何桂珍, 齐志伟, 等.缺血性脑卒中对犬肠屏障功能的影响[J].中华临床营养杂志, 2012, 20:243-247. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zglcyyzz201204008 [10] Hay M, Meunier-Salaun MC, Brulaud F, et al. Assessment of hypothalamic-pituitary-adrenal axis and sympathetic nervous system activity in pregnant sows through the measurement of glucocorticoids and catecholamines in urine[J]. J Anim Sci, 2000, 78:420-428. doi: 10.2527/2000.782420x [11] Lee H, Park JH, Park DI, et al. Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome[J]. Neurogastroenterol Motil, 2013, 19:244-250. doi: 10.5056/jnm.2013.19.2.244 [12] Smith SR, de Jonge L, Pellymounter M, et al. Peripheral administration of human corticotropin-releasing hormone:a novel method to increase energy expenditure and fat oxidation in man[J]. J Clin Endocrinol Metab, 2001, 86:1991-1998. https://www.ncbi.nlm.nih.gov/pubmed/11344197 [13] Overton JM, Fisher LA. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats[J]. J Auton Nerv Syst, 1991, 35:43-51. doi: 10.1016/0165-1838(91)90037-4 [14] Kanamoto K, Urdanda A, Rivier J, et al. Intravenous urocortin Ⅱ induced gastroprotection and gastric hyperemia in anesthetized rats:role of CRF receptor 2[J]. Gastroenterology, 2001, 122:A-13. http://www.researchgate.net/publication/295451047_Intravenous_urocortin_II_induced_gastroprotection_and_gastric_hyperemia_in_anesthetized_rats_Role_of_CRF_receptor_2 [15] Alysandratos KD, Asadi S, Angelidou A, et al. Neurotensin and CRH interactions augment human mast cell activation[J].PLoS One, 2012, 7:e48934. doi: 10.1371/journal.pone.0048934 [16] Sun Y, Zhang M, Chen CC, et al.Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice[J]. Gastroente-rology, 2013, 144:1478-1487. doi: 10.1053/j.gastro.2013.02.038 [17] Saunders PR, Santos J, Hanssen NP, et al. Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH[J]. Dig Dis Sci, 2002, 47:208-215. doi: 10.1023/A:1013204612762 [18] Gabry KE, Chrousos GP, Rice KC, et al. Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs[J]. Mol Psychiatry, 2002, 7:474-483. doi: 10.1038/sj.mp.4001031 [19] Weiner H. Use of animal models in peptic ulcer disease[J]. Psychosom Med, 1996, 58:524-545. doi: 10.1097/00006842-199611000-00002 [20] Gourcerol G, Wu SV, Yuan PQ, et al. Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents[J]. Gastroentero-logy, 2011, 140:1586-1596. doi: 10.1053/j.gastro.2011.01.039 [21] Ray A, Henke PG, Gulati K, et al. The amygdaloid complex, corticotrophin releasing factor and stress-induced gastric ulcerogenesis in rats[J]. Brain Res, 1993, 624:286-290. doi: 10.1016/0006-8993(93)90089-6 [22] Gunion MW, TachS Y. Gastric mucosal damage is inhibited by intraventromedial hypothalamic corticotropin-releasing factor[J]. Soc Neurosci Abstr, 1986, 12:644. [23] Krahn DD, Wright B, Billington CJ, et al. Exogenous corticotropin-releasing factor inhibits stress-induced gastric ulceration[J]. Soc Neurosci Abstr, 1986, 12:1063. [24] Esposito P, Chandler N, Kandere K, et al. Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress[J]. J Pharmacol Exp Ther, 2002, 303:1061-1066. doi: 10.1124/jpet.102.038497 [25] Hendryk S, Jedrzejowska-Szypulka H, Josko J, et al. Influence of the corticotropin releasing hormone (CRH) on the brain-blood barrier permeability in cerebral ischemia in rats[J]. J Physiol Pharmacol, 2002, 53:85-94. http://www.jpp.krakow.pl/journal/archive/03_02/pdf/85_03_02_article.pdf [26] Martins JM, Banks WA, Kastin AJ. Transport of CRH from mouse brain directly affects peripheral production of beta-endorphin by the spleen[J]. Am J Physiol, 1997, 273:E1083-E1089. http://europepmc.org/abstract/MED/29585414 [27] Martins JM, Kastin AJ, Banks WA. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone[J]. Neuroendocrinology, 1996, 63:338-348. doi: 10.1159/000126974